23/01/2026
The 11th HIV Cure Community-led Workshop was held on 15 October 2025, in Paris, France at the conference. The workshop discussed approaches for HIV cure research, provided updates on upcoming trials on therapeutic vaccination, and stressed the importance of the contributions of the community.
⤵️ This is a summary report from the workshop.
https://www.eatg.org/publications/steps-11-a-community-initiative-to-design-the-pathway-to-a-durable-art-free-control-of-hiv-infection-summary-report/
Highlights
· Ongoing reconsent and long-term follow-up are becoming increasingly important components of ATI trials.
· The EU2Cure platform aims to connect post-treatment controllers who are interested in HIV cure research with investigators.
· A major complexity of HIV cure trials lies in the emotional and ethical challenge of communicating a positive HIV diagnosis while simultaneously proposing trial enrolment.
· Even when information is presented in a highly explicit and transparent manner, participants may still experience a degree of hope (of HIV control, without treatment), highlighting the need for tailored tools alongside oral communication.
· Frequencies of HTI-specific T-cells associated with improved viral control could inform the design of future HIV cure trials.
· In a context of diminishing political attention, tightening funding and increasing pressure on health systems, community participation is not merely desirable - it is essential.
European AIDS Clinical Society
The 11th STEPS HIV Cure community-led workshop took place on 15 October 2024 in Paris ahead of the EACS 2025 conference. This is a summary report from the workshop.